Evidence map›Paper›PMID 28831119›Full record

ArticleScientific reports2017

Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection.

Qi Wu, Lina Zhou, Xin Sun, Zhongfang Yan, Chunxiu Hu, Junping Wu, Long Xu, Xue Li, Huiling Liu, Peiyuan Yin and 8 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04661930 (A Study of a 10-days Fenofibrate Treatment, or Until Discharge From Hospital, Among COVID-19 Infected Patients Requiring Hospitalization), which is not on this map. Cited by 251 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
251citing papers in PubMed, 5 pooled it
23.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04661930 phase3unknown statusnot on this mapstarted 2021, after this paper: background citation

A Study of a 10-days Fenofibrate Treatment, or Until Discharge From Hospital, Among COVID-19 Infected Patients Requiring Hospitalization

TypeinterventionalSponsorYaakov NahmiasRan2021 to 2022Enrolled55ConditionsCorona Virus Disease (COVID-19), Respiratory Distress Syndrome, SARS-CoV-2 InfectionArmsTriCor® 145mg tablets, Placebo, Usual care
3 · Its place in the literature

Who cites it

251 citing papers in PubMed, 5 syntheses or guidelines pooled it, 450 citations in OpenAlex.

  1. Pooled it
  2. New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection-Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Pathogenic mechanisms of cardiovascular damage in COVID-19.Molecular medicine (Cambridge, Mass.) · 2024
    Review
  20. Article

191 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Qi WuKey Research Laboratory for Infectious Disease Prevention for State Administration of Traditional Chinese Medicine, Tianjin Institute of Respiratory Diseases, Haihe Clinical College of Tianjin Medical University, Tianjin, China.
Lina ZhouCAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China.
Xin SunDepartment of Respiratory Medicine, Tianjin Haihe Hospital, Tianjin, China.
Zhongfang YanDepartment of Nutrition, Tianjin Haihe Hospital, Tianjin, China.
Chunxiu HuCAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China.
Junping WuDepartment of Respiratory Medicine, Tianjin Haihe Hospital, Tianjin, China.
Long XuDepartment of Respiratory Medicine, Tianjin Haihe Hospital, Tianjin, China.
Xue LiDepartment of Basic Medicine, Tianjin Haihe Hospital, Tianjin, China.
Huiling LiuDepartment of Gastroenterology, Tianjin Haihe Hospital, Tianjin, China.
Peiyuan YinCAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China.
Kuan LiDepartment of Basic Medicine, Tianjin Haihe Hospital, Tianjin, China.
Jieyu ZhaoCAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China.
Yanli LiCAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China.
Xiaolin WangCAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China.
Yu LiDepartment of Basic Medicine, Tianjin Haihe Hospital, Tianjin, China.
Qiuyang ZhangDepartment of Basic Medicine, Tianjin Haihe Hospital, Tianjin, China.
Guowang XuCAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China. xugw@dicp.ac.cn.ORCID 0000-0003-4298-3554
Huaiyong ChenKey Research Laboratory for Infectious Disease Prevention for State Administration of Traditional Chinese Medicine, Tianjin Institute of Respiratory Diseases, Haihe Clinical College of Tianjin Medical University, Tianjin, China. huaiyong.chen@foxmail.com.
Tianjin haihe hospital · CNDalian Institute of Chemical Physics · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome-coronavirus (SARS-CoV) and SARS-like coronavirus are a potential threat to global health. However, reviews of the long-term effects of clinical treatments in SARS patients are lacking. Here a total of 25 recovered SARS patients were recruited 12 years after infection. Clinical questionnaire responses and examination findings indicated that the patients had experienced various diseases, including lung susceptibility to infections, tumors, cardiovascular disorders, and abnormal glucose metabolism. As compared to healthy controls, metabolomic analyses identified significant differences in the serum metabolomes of SARS survivors. The most significant metabolic disruptions were the comprehensive increase of phosphatidylinositol and lysophospha tidylinositol levels in recovered SARS patients, which coincided with the effect of methylprednisolone administration investigated further in the steroid treated non-SARS patients with severe pneumonia. These results suggested that high-dose pulses of methylprednisolone might cause long-term systemic damage associated with serum metabolic alterations. The present study provided information for an improved understanding of coronavirus-associated pathologies, which might permit further optimization of clinical treatments.

Indexed as

Lipid MetabolismSevere acute respiratory syndrome-related coronavirusAdultFemaleFollow-Up StudiesHumansLipidsMaleMetabolic Networks and PathwaysMetabolomeMetabolomicsMiddle AgedPublic Health SurveillanceRisk FactorsSevere Acute Respiratory SyndromeSteroidsLipidsSteroids

Identifiers

PMID28831119
PMCPMC5567209
OpenAlexW2746482698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.